Williams R, Byamugisha A, Davis-Ewart L, Valentin O, Dilworth S, Grov C
Prev Med Rep. 2025; 50:102986.
PMID: 39911834
PMC: 11795108.
DOI: 10.1016/j.pmedr.2025.102986.
Schade P, Nguyen H, Steinle J, Hellwig K, Pelea T, Franken P
Ther Adv Neurol Disord. 2025; 18:17562864241309806.
PMID: 39866752
PMC: 11760134.
DOI: 10.1177/17562864241309806.
Te Linde E, Hensgens M, Vollaard A, Verbon A, Bruns A
Vaccines (Basel). 2025; 12(12.
PMID: 39772045
PMC: 11680350.
DOI: 10.3390/vaccines12121383.
Evans S, Schmitt J, Kalra D, Sokol T, Holt D
Front Public Health. 2025; 12:1407841.
PMID: 39741942
PMC: 11685149.
DOI: 10.3389/fpubh.2024.1407841.
Debbag R, Rudin D, Ceddia F, Watkins J
Infect Dis Ther. 2024; 14(Suppl 1):63-97.
PMID: 39739199
PMC: 11724835.
DOI: 10.1007/s40121-024-01079-x.
What makes patients tick? Vaccine preferences against tick-borne encephalitis in four European countries.
Zacharias C, Torgler R, Cummins J
BMC Infect Dis. 2024; 24(1):1151.
PMID: 39396966
PMC: 11472448.
DOI: 10.1186/s12879-024-10045-4.
Healthcare personnel acceptance and recommendations for influenza vaccine in twelve low- and middle-income countries: A pooled analysis from 2018 to 2020.
McCarron M, Marcenac P, Yau T, Lafond K, Ebama M, Duca L
Vaccine. 2024; 42 Suppl 4:125670.
PMID: 39198045
PMC: 11464209.
DOI: 10.1016/j.vaccine.2024.01.095.
An ecological analysis of socio-economic determinants associated with paediatric vaccination coverage in the Campania Region: A population-based study, years 2003-2017.
Mercogliano M, Valdecantos R, Fevola G, Sorrentino M, Buonocore G, Triassi M
Vaccine X. 2024; 18:100482.
PMID: 38585381
PMC: 10997839.
DOI: 10.1016/j.jvacx.2024.100482.
Knowledge, Attitudes, and Coverage of Recommended Vaccinations in Individuals with Chronic Medical Conditions: A Cross-Sectional Telephone Survey in Italy.
Sansone V, Miraglia Del Giudice G, Della Polla G, Angelillo I
Vaccines (Basel). 2024; 12(3).
PMID: 38543970
PMC: 10974983.
DOI: 10.3390/vaccines12030336.
Promoting informed decision making about maternal pertussis vaccination: the systematic development of an online tailored decision aid and a centering-based group antenatal care intervention.
Anraad C, van Empelen P, Ruiter R, Rijnders M, van Groessen K, van Keulen H
Front Public Health. 2024; 12:1256337.
PMID: 38425460
PMC: 10902124.
DOI: 10.3389/fpubh.2024.1256337.
Rollout of the 2022/2023 Seasonal Influenza Vaccination and Correlates of the Use of Enhanced Vaccines among Italian Adults.
Pestarino L, Domnich A, Orsi A, Bianchi F, Cannavino E, Brasesco P
Vaccines (Basel). 2023; 11(12).
PMID: 38140153
PMC: 10747154.
DOI: 10.3390/vaccines11121748.
The Role of Adult Vaccines as Part of Antimicrobial Stewardship: A Scoping Review.
Williams C, Zaidi S, Saini B, Castelino R
Antibiotics (Basel). 2023; 12(9).
PMID: 37760725
PMC: 10525636.
DOI: 10.3390/antibiotics12091429.
Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination.
Kim J, Jung J, Suh C, Ye Y, Kim H
J Korean Med Sci. 2023; 38(32):e247.
PMID: 37582497
PMC: 10427213.
DOI: 10.3346/jkms.2023.38.e247.
Effectiveness of repetitive influenza vaccination against SARS-CoV-2 infection among a cohort of health care workers in Portugal.
Sa Silva S, Severo M, Norton P, Moreira A
Porto Biomed J. 2023; 8(4):e223.
PMID: 37547709
PMC: 10400066.
DOI: 10.1097/j.pbj.0000000000000223.
Measles and Varicella Vaccination Program in a Hospital: Implementation and Impact on Contact Tracing.
Loi A, Sridhar R, Lim S
Vaccines (Basel). 2023; 11(7).
PMID: 37514947
PMC: 10385976.
DOI: 10.3390/vaccines11071131.
Vaccination process of immunocompromised patients in the Netherlands: Current challenges and potential solutions.
de Laat C, Simons J, Westra T, Hiligsmann M
Vaccine X. 2023; 14:100340.
PMID: 37448977
PMC: 10336781.
DOI: 10.1016/j.jvacx.2023.100340.
Understanding COVID-19 vaccine hesitancy in Malaysia: Public perception, knowledge, and acceptance.
Mohamed N, Solehan H, Mohd Rani M, Ithnin M, Arujanan M
PLoS One. 2023; 18(4):e0284973.
PMID: 37104381
PMC: 10138221.
DOI: 10.1371/journal.pone.0284973.
Understanding the factors that influence communication about COVID-19 vaccines with patients: Perspectives of Australian immunisation providers.
Abdi I, Bolsewicz K, Bullivant B, Marques M, Steffens M
Vaccine X. 2023; 14:100304.
PMID: 37091729
PMC: 10108559.
DOI: 10.1016/j.jvacx.2023.100304.
Dutch Healthcare Professionals' Opinion on the Allocation of Responsibilities concerning Prescribing and Administering Medically Indicated Vaccines to Immunocompromised Patients.
Te Linde E, Doornekamp L, Daenen K, van Gorp E, Bruns A
Vaccines (Basel). 2023; 11(3).
PMID: 36992271
PMC: 10058813.
DOI: 10.3390/vaccines11030686.
Safer at school early alert: an observational study of wastewater and surface monitoring to detect COVID-19 in elementary schools.
Fielding-Miller R, Karthikeyan S, Gaines T, Garfein R, Salido R, Cantu V
Lancet Reg Health Am. 2023; 19:100449.
PMID: 36844610
PMC: 9939935.
DOI: 10.1016/j.lana.2023.100449.